Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Saturday, May 18, 2024 | Back issues
Courthouse News Service Courthouse News Service

Pharma IPO Class Action

ProNAi Therapeutics raised $144 million in its IPO at $17 a share, then the price dropped to $1.53 when its cancer drug failed, shareholders say in a class action in San Mateo County Court.

REDWOOD CITY, Calif. – ProNAi Therapeutics raised $144 million in its IPO at $17 a share, then the price dropped to $1.53 when its cancer drug failed, shareholders say in a class action in San Mateo County Court.

Categories / Business, Securities

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...